Medincell secures EUR 13.8 million non — dilutive loan from European banks, Bpifrance

Medincell secured an additional EUR 13.8 million non-dilutive loan from leading European commercial banks and Bpifrance. Total non-dilutive financing raised since July 2026 increased to EUR 41.8 million, including EUR 28 million announced in July 2026. Loan terms were described as market-based, with no instruments providing access to equity, avoiding shareholder dilution. Cash and cash equivalents stood at EUR 84.8 million as of March 31, 2026. Medincell repaid EUR 23.2 million to the EIB in July 2026, including EUR 20 million of principal. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medincell SA published the original content used to generate this news brief via (Ref. ID: 20261013399867) on October 13, 2026, and is solely responsible for the information contained therein. (C)